系统性红斑狼疮B细胞活化后PD-1升高而PD-L1上调能力减弱
研究评估29例SLE患者和27例健康供者B细胞在基线和体外刺激后PD-1、PD-L1、PD-L2的表达及其与B细胞增殖的关系。SLE B细胞在IL-2/IL-10、抗BCR、CpG和CD40L刺激48小时后PD-L1上调能力显著减弱(P=0.0006),且B细胞增殖降低(P=0.0039);PD-L1降低与干扰素特征呈负相关(r=-0.8571,P<0.0001),与SLEDAI评分呈负相关(r=-0.5696,P=0.0087)。
要点
- SLE患者未刺激B细胞和T细胞PD-1表达升高。
- SLE B细胞刺激后PD-L1上调能力显著减弱且增殖降低。
- PD-L1降低与干扰素特征和SLEDAI评分负相关。
核心结论
- 活化后低反应的狼疮B细胞表现为PD-1升高、PD-L1上调功能减弱及刺激后增殖降低。
研究设计与样本
- 研究纳入29例SLE患者和27例健康供者,分离外周血单个核细胞,用IL-2/IL-10、抗BCR、CpG和CD40L单独或联合刺激,流式细胞术检测基线及刺激48小时后B细胞亚群和CD3+ T细胞的PD-1、PD-L1、PD-L2表达,并以CD71评估CD19+CD20+ B细胞增殖。
主要发现
- 未刺激的狼疮B细胞和T细胞PD-1表达升高。
- SLE B细胞经IL-2/IL-10、抗BCR、CpG和CD40L刺激48小时后,PD-L1上调能力显著减弱(P=0.0006)。
- SLE B细胞刺激后增殖降低(P=0.0039)。
- PD-L1表达降低与干扰素特征呈负相关(r=-0.8571,P<0.0001)。
- PD-L1表达降低与SLEDAI评分呈负相关(r=-0.5696,P=0.0087)。
临床怎么用
- SLE患者B细胞PD-1升高和PD-L1上调缺陷可作为评估B细胞低反应状态的免疫学指标。
- PD-L1表达降低与干扰素特征和疾病活动度相关,提示监测B细胞PD-L1可能有助于判断SLE活动性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the expression of programmed death 1 (PD-1), PD ligand 1 (PD-L1), and PD-L2 by B cells from patients with systemic lupus erythematosus (SLE) at baseline and after in vitro stimulation and to analyze their functional relationship to B cell proliferation. METHODS: Peripheral blood mononuclear cells obtained from 29 SLE patients and 27 healthy donors were stimulated with interleukin-2 (IL-2)/IL-10, anti-B cell receptor (anti-BCR), CpG, and CD40L alone or in combination. Expression of PD-1, PD-L1, and PD-L2 on defined B cell subsets as well as on CD3+ T cells was analyzed by flow cytometry at baseline and after 48 hours of stimulation. Additionally, after 48 hours of stimulation, CD71 was evaluated as a proliferation marker on CD19+CD20+ B cells. RESULTS: Increased PD-1 expression was characteristic of unstimulated lupus B cells and T cells. Upon stimulation of B cells with IL-2/IL-10, anti-BCR, CpG, and CD40L for 48 hours, the capacity of SLE B cells to up-regulate PD-L1 expression was substantially diminished (P = 0.0006) along with reduced B cell proliferation (P = 0.0039). Reduced PD-L1 expression was inversely correlated with the presence of the interferon signature (r = -0.8571, P < 0.0001) and the clinical SLE Disease Activity Index score (r = -0.5696, P = 0.0087). CONCLUSION: Post-activated, hyporesponsive lupus B cells are characterized by a phenotype of increased PD-1, functionally diminished PD-L1 up-regulation capacity, and reduced proliferation upon stimulation.
引用
- Stefanski AL, Wiedemann A, Reiter K, et al. Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B Cells. Arthritis Rheumatol. 2019. PMID: 30919595. doi:10.1002/art.40897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。